Keryx Biopharmaceuticals Inc fka KERX

[cameron12x]

Open Letter to Adam Feuerstein

Many have read your recent chirp at "The Street" regarding the prospects of Keryx's P3 trial-approved drug Zerenex.

It is well known throughout the biotech investment community that you are a paid "sell-side" analyst, serving the special interest needs of your hedge fund masters. We understand that you haven't liked Keryx for a very long time.

If you feel really secure in your position, please elucidate this to us in your favorite forum (Seeking Alpha), where factual rebuttals and intelligent dialogue can occur?

Don't coddle behind the walls of "The Street," Mr. Feuerstein. Aren't you bigger than that?